denosumab - bmwo - denosumab - bmwo injection
(Denosumab-Bmwo)Celltrion Usa, Inc.
Usage: Denosumab-bmwo is indicated for preventing skeletal-related events in multiple myeloma and bone metastases, treating unresectable giant cell tumor of bone in adults and adolescents, and managing hypercalcemia of malignancy that is resistant to bisphosphonate therapy.